Clinical Trial Update: n-3 Polyunsaturated Fatty Acids (PUFA) Supplementation in Young Women With Polycystic Ovary Syndrome (PCOS) [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of n-3 polyunsaturated fatty acids (PUFA) supplementation in young women with Polycystic Ovary Syndrome (PCOS)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• n-3 polyunsaturated fatty acids (PUFA) supplementation (n-3 polyunsaturated fatty acids)

Snippet

Sponsor: The Adelaide and Meath Hospital | Conditions: Polycystic Ovary Syndrome | NA | Status: COMPLETED